General
Emergency authorisation sought for coronavirus vaccines by Pfizer and Oxford-AstraZeneca in India
Emergency authorisation has been sought for the use of Pfizer and Oxford-AstraZeneca’s coronavirus vaccines in India, following the lead of the UK and Russia.
Key points:
- India has reported the second-highest number of coronavirus cases in the world
- The chief executive of one of the world’s largest vaccine producers said approval would “save countless lives”
- Experts say distribution of Pfizer’s vaccine may be difficult in India because it needs to be kept below -70 degrees Celsius
The Serum Institute of India, the world’s largest vaccine producer by volume, sought emergency authorisation in the country for Oxford-AstraZeneca’s COVID-19 vaccine.
The move came close on the heels of Pfizer applying for a similar authorisation of its coronavirus…
Continue Reading
-
General8 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
General11 hours agoAlbanese beats drum on economy as trade clouds gather
-
Business7 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
Noosa News10 hours agoSurgeon partner of former premier to testify over his patient’s death